Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ankor Holding is a Turkish private holding company with businesses spanning construction, real estate, information technology, and healthcare. Within healthcare, the group has invested since the 1990s in private imaging, medical technology distribution, biomedical engineering, and robotic surgery-related activities. Its healthcare subsidiaries include Medicall Biomedikal, Mekomed Medikal, and Cordamed, which focus on areas such as cardiology, cardiovascular surgery, radiology, medical devices, and biomedical engineering services across Turkey. The company appears to operate as a commercial services and distribution group rather than a drug-development biotech or pharmaceutical developer, and no proprietary therapeutic pipeline was identified. For a biotech analyst, the most relevant framing is that Ankor Holding is a diversified commercial healthcare and medtech holding company with national operations in Turkey.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ankor Holding.